Voorbeelden van het gebruik van Procysbi in het Engels en hun vertalingen in het Nederlands
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
How does Procysbi work?
Other information about Procysbi.
How is Procysbi used?
Procysbi is a‘hybrid medicine.
Clinical studies experience with PROCYSBI.
Why is Procysbi approved?
Important information about some of the ingredients of PROCYSBI.
PROCYSBI can be taken with sodas once degasified.
The reference medicine for Procysbi is Cystagon.
What PROCYSBI looks like and contents of the pack?
Food intake two hours after administration did not affect the absorption of PROCYSBI.
PROCYSBI 25 mg is presented as blue gastro-resistant hard capsules.
1 hour after PROCYSBI dosing.
PROCYSBI is indicated for the treatment of proven nephropathic cystinosis.
You should contact your doctor or the hospital emergency department immediately if you have taken more PROCYSBI than you should.
Treatment with PROCYSBI should continue life-long,
Bicarbonate should be administered at least one hour before or one hour after PROCYSBI to avoid potential earlier release of cysteamine.
Procysbi is a medicine that contains the active substance mercaptamine also known as cysteamine.
1 hour after PROCYSBI dosing.
PROCYSBI should not be administered with food rich in fat
A bacterial reverse mutation assay study(“Ames test”) was performed with the cysteamine bitartrate used for PROCYSBI and cysteamine bitartrate did not show any mutagenic effects in this test.
Procysbi must not be used in people who are hypersensitive(allergic)
determine adequacy of dosing, levels being measured 30 minutes after dosing when treated with PROCYSBI.
PROCYSBI contains the active substance cysteamine(also known as mercaptamine)
Because the number of patients with cystinosis is low, the disease is considered‘rare', and Procysbi was designated an‘orphan medicine'(a medicine used in rare diseases) on 20 September 2010.
The CHMP noted that Procysbi was shown to be at least as effective as Cystagon at maintaining the amount of cystine in white blood cells at acceptable levels.
This means that it is similar to a‘reference medicine' containing the same active substance, but Procysbi is available in a formulation that allows for a delayed release of the active substance in the body.
Procysbi given every 12 hours has been shown to be at least as effective as Cystagon given every 6 hours at maintaining the amount of cystine in white blood cells at acceptable levels less than 1 nmol hemicystine per mg of white blood cell protein.
the CHMP considered that the safety profile of mercaptamine is well established and the safety of Procysbi is expected to be similar to that of the reference medicine.
The most common side effects with Procysbi(which may affect more than 1 in 10 people)